Sponsor Pipeline

Guangzhou FineImmune Biotechnology Co., LTD. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
5
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1
5
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT03891706 Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors Solid Tumor Recruiting
NCT06302062 Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid… Advanced Solid Tumor Recruiting
NCT06716619 A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant… Tumor Associated Lymph Node T Cell Recruiting
NCT06942143 An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With… Sarcoma Recruiting
NCT07493044 An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced… Advanced Hepatocellular Carcinoma (HCC) Recruiting
Disease Areas
Get alerts when Guangzhou FineImmune Biotechnology Co., LTD.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free